Sequoia China exceeds target

Despite a drop in venture capital deals across Asia, the firm raised close to $350m for its fourth China fund while OrbiMed, another VC, launches its Asia-focus vehicle.

ByClare Burrows

19 September 2013•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Asia-Pacific East Asia North America

Sequoia China exceeds target

OrbiMed Advisors

Thomson Reuters

Related articles